Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Min Shen

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 18, 2017
A case of autoimmune severe acquired von Willebrand syndrome (type 3-like)Chakri Gavva, Prapti Patel, Yu-Min Shen, et al.
British Journal of Haematology|February 1, 2006
Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapyRavindra Sarode, Ajay Rawal, Ray Lee, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 17, 2011
Lupus anticoagulant interference in activated protein C resistance testing: in vitro phenomenon or in vivo pathophysiologic effect?Yu-Min Shen, Michael L Cimo, Yu Bai, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 6, 2016
Can an anti-Xa assay for low-molecular-weight heparin be used to assess the presence of rivaroxaban?Sean G Yates, Sabra Smith, William Tharpe, et al.
Healthcare (Basel, Switzerland)|February 25, 2023
Short Video Addiction on the Interaction of Creative Self-Efficacy and Career Interest to Innovative Design Profession StudentsI-Tung Lin, Yu-Min Shen, Mei-Jen Shih, et al.
Chemical Research in Toxicology|November 23, 2006
Comparison of p53 mutations induced by PAH o-quinones with those caused by anti-benzo[a]pyrene diol epoxide in vitro: role of reactive oxygen and biological selectionYu-Min Shen, Andrea B Troxel, Srilakshmi Vedantam, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 10, 2011
Incidence of isolated heparin-induced thrombocytopenia and risk of thrombosis by IgG-specific anti-PF4/heparin ELISASofyan M Radaideh, Eugene P Frenkel, Jonathan E Dowell, et al.
Cureus|April 30, 2025
Perioperative Hemostasis Management During Open Mitral Valve Replacement in a Patient With Hypoprothrombinemia Secondary to Lupus AnticoagulantObieze Nwanna-Nzewunwa, Tayyaba M Malik, Melissa Bellomy, et al.
Transfusion|October 3, 2024
How do we manage hyperhemolysis syndromeBrian D Adkins, Samer Z Kaylani, Alecia Nero, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 3, 2020
Comparison of low fixed dose versus standard-dose rituximab to treat thrombotic thrombocytopenic purpura in the acute phase and preemptively during remissionManasa S Reddy, Sandra Hofmann, Yu Min Shen, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 18, 2017
A case of autoimmune severe acquired von Willebrand syndrome (type 3-like)Chakri Gavva, Prapti Patel, Yu-Min Shen, et al.
British Journal of Haematology|February 1, 2006
Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapyRavindra Sarode, Ajay Rawal, Ray Lee, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 17, 2011
Lupus anticoagulant interference in activated protein C resistance testing: in vitro phenomenon or in vivo pathophysiologic effect?Yu-Min Shen, Michael L Cimo, Yu Bai, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 6, 2016
Can an anti-Xa assay for low-molecular-weight heparin be used to assess the presence of rivaroxaban?Sean G Yates, Sabra Smith, William Tharpe, et al.
Healthcare (Basel, Switzerland)|February 25, 2023
Short Video Addiction on the Interaction of Creative Self-Efficacy and Career Interest to Innovative Design Profession StudentsI-Tung Lin, Yu-Min Shen, Mei-Jen Shih, et al.
Chemical Research in Toxicology|November 23, 2006
Comparison of p53 mutations induced by PAH o-quinones with those caused by anti-benzo[a]pyrene diol epoxide in vitro: role of reactive oxygen and biological selectionYu-Min Shen, Andrea B Troxel, Srilakshmi Vedantam, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 10, 2011
Incidence of isolated heparin-induced thrombocytopenia and risk of thrombosis by IgG-specific anti-PF4/heparin ELISASofyan M Radaideh, Eugene P Frenkel, Jonathan E Dowell, et al.
Cureus|April 30, 2025
Perioperative Hemostasis Management During Open Mitral Valve Replacement in a Patient With Hypoprothrombinemia Secondary to Lupus AnticoagulantObieze Nwanna-Nzewunwa, Tayyaba M Malik, Melissa Bellomy, et al.
Transfusion|October 3, 2024
How do we manage hyperhemolysis syndromeBrian D Adkins, Samer Z Kaylani, Alecia Nero, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 3, 2020
Comparison of low fixed dose versus standard-dose rituximab to treat thrombotic thrombocytopenic purpura in the acute phase and preemptively during remissionManasa S Reddy, Sandra Hofmann, Yu Min Shen, et al.
Pageof 5